1
|
Miao C, Qin D, Cao P, Lu P, Xia Y, Li M, Sun M, Zhang W, Yang F, Zhang Y, Tang S, Liu T, Liu F. BMP2/7 heterodimer enhances osteogenic differentiation of rat BMSCs via ERK signaling compared with respective homodimers. J Cell Biochem 2019; 120:8754-8763. [PMID: 30485526 DOI: 10.1002/jcb.28162] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2018] [Accepted: 11/05/2018] [Indexed: 01/24/2023]
Abstract
Bone morphogenetic protein (BMP)2/7 heterodimer shows greater efficacy in enhancing bone regeneration. However, the precise mechanism and the role of mitogen-activated protein kinase (MAPK) signaling network in BMP2/7-driven osteogenesis remain ambiguous. In this study, we evaluated the effects of BMP2/7 heterodimers on osteoblastic differentiation in rat bone marrow mesenchymal stem cells (BMSCs), with the aim to elaborate how MAPKs might be involved in this cellular process by treatment of rat BMSCs with BMP2/-7 with a special signal-pathway inhibitor. We found that BMP2/7 heterodimer induced a much stronger osteogenic response in rat BMSCs compared with either homodimer. Most interestingly, extracellular signal-regulated kinase (ERK) demonstrated a highly sustained phosphorylation and activation in the BMP2/7 heterodimer treatment groups, and inhibition of ERK cascades using U0126 special inhibitor that significantly reduced the activity of ALP and calcium mineralization to a substantial degree in rat BMSCs treated with BMP2/7 heterodimers. Collectively, we demonstrate that BMP2/7 heterodimer shows a potent ability to stimulate osteogenesis in rat BMSCs. The activated ERK signaling pathway involved in this process may contribute partially to an increased osteogenic potency of heterodimeric BMP2/7 growth factors.
Collapse
Affiliation(s)
- Chunlei Miao
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| | - Dengke Qin
- Department of Plastic and Cosmetic Surgery, HuaDong Hospital, Fudan University, Shanghai, China
| | - Peigang Cao
- Department of Stomatology, Weifang People's hospital, Weifang, Shandong, China
| | - Ping Lu
- Department of Obstetrics and Gynecology, Zhucheng People's Hospital, Zhucheng, Shandong, China
| | - Yutong Xia
- Department of Plastic and Cosmetic Surgery, HuaDong Hospital, Fudan University, Shanghai, China.,Department of Academic Support, Shanghai Pinghe School, Shanghai, China
| | - Mengjiao Li
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| | - Miao Sun
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| | - Wei Zhang
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| | - Fanghong Yang
- Department of Stomatology, Weifang People's hospital, Weifang, Shandong, China
| | - Yingjie Zhang
- Division of Research & Development, Eugenom Inc, San Diego, CA
| | - Shengjian Tang
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| | - Tianyi Liu
- Department of Plastic and Cosmetic Surgery, HuaDong Hospital, Fudan University, Shanghai, China
| | - Fangjun Liu
- Division of Plastic Surgery, Institute of Plastic and Reconstructive Surgery, Hospital for Plastic Surgery, Weifang Medical University, Weifang, Shandong, China
| |
Collapse
|